Drug Shortage Report for AA-FENO-SUPER
| Report ID | 3524 |
| Drug Identification Number | 02246860 |
| Brand name | APO-FENO-SUPER |
| Common or Proper name | FENOFIBRATE |
| Company Name | AA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | FENOFIBRATE |
| Strength(s) | 160MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 BLS |
| ATC code | C10AB |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2017-10-18 |
| Estimated end date | 2018-06-22 |
| Actual end date | 2018-05-11 |
| Shortage status | Resolved |
| Updated date | 2018-05-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2017-03-23 | English | Compare |
| v3 | 2017-03-21 | English | Compare |
| v2 | 2017-03-20 | French | Compare |
| v1 | 2017-03-20 | English | Compare |